Finotonlimab
Based on 1 Customer Validation
Finotonlimab (SCT-I10A) is a recombinant humanised IgG PD-1 antibody. Finotonlimab has the potential for solid tumors or lymphomas research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 97.50%
- CAS. Nr.: 2350298-85-8
- Molecular Weight:145.38 kDa
-
Speicherung:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Isotype
Human IgG4 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
PDCD1/PD-1/CD279
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG4 kappa
Anwendung
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized PD-1 Protein, Human (143a.a, HEK293, His, HY-P7396) can bind Finotonlimab. The EC50 for this effect is 6.551 ng/mL.
Chemical Information
-
CAS. Nr. 2350298-85-8
-
Appearance Liquid
-
Molecular Weight 145.38 kDa
-
Color Colorless to light yellow
-
SMILES
[Finotonlimab]
-
Synonyms
SCT-I10A
-
Versand
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
Data Sheet (254 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)